Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;141(1):200-6.
doi: 10.1017/S0950268812000325. Epub 2012 Mar 12.

Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005

A W Armstrong  1 , K H Lam, E P Chase
Affiliations

Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005

A W Armstrong et al. Epidemiol Infect. 2013 Jan.

Abstract

This study aimed to examine trends in incidence, geographical distribution, and survival of classic and AIDS-related Kaposi's sarcoma (KS) in the general US population using Surveillance, Epidemiology, and End Results (SEER) tumour registries with 12 066 patients diagnosed with KS between 1975 and 2005. Although the age-adjusted standardized incidence ratio (SIR) of AIDS-related KS (1·9) during 1980-2005 was not significantly higher than that of classic KS (1·4) during 1975-2005 (P = 0·78), the trends in annual SIR rates revealed distinct patterns. While the SIR for AIDS-related KS declined across all registries from the early 1990s (4·6) to late-1990s (0·3) (P = 0·05), the SIR of classic KS remained relatively steady (1·7). In both forms the SIR of KS was highest in metropolitan areas. The 5-year survival rates for patients with AIDS-related KS improved from 12·1% (1980-1995) to 54% (1996-2005) (P = 0·05). Survival rates for patients with classic KS remained stable, ranging from 75·7% to 88·6% during the 30-year period. These results may reflect improved HIV treatment.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Trends and standardized incidence ratio (SIR)* for (a) AIDS-related Kaposi's sarcoma and (b) classic Kaposi's sarcoma in the US population from 1980 to 2005 (SEER-9). (* SIR per 100 000 people per year, age-standardized to the 2000 US population. Relative changes in rate across nine SEER registries shown on a linear scale; P < 0·05.) SEER, Surveillance Epidemiology and End Results.
Fig. 2
Fig. 2
[colour online]. Comparison of the standardized incidence ratio (SIR) of classic and AIDS-related Kaposi's sarcoma (KS) based on geographical distribution in the US population from 1980 to 2005. Distribution based on the SEER-9 registries. SEER, Surveillance Epidemiology and End Results.
See this image and copyright information in PMC

References

    1. Bagni R, Whitby D. Kaposi's sarcoma-associated herpesvirus transmission and primary infection. Current Opinion in HIV and AIDS 2009; 4: 22–26. - PubMed
    1. Gazouli M, et al. Human herpesvirus type 8 genotypes in iatrogenic, classic and AIDS-associated Kaposi's sarcoma from Greece. Anticancer Research 2004; 24: 1597–1602. - PubMed
    1. Rosenberg PS, Biggar RJ. Trends in HIV incidence among young adults in the United States. Journal of the American Medical Association 1998; 279: 1894–1899. - PubMed
    1. Biggar RJ, Curtis RE, Cote TR, Rabkin CS, Melbye M. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. American Journal of Epidemiology 1994; 139: 362–368. - PubMed
    1. Osmond DH, et al. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. Journal of the American Medical Association 2002; 287: 221–225. - PubMed